Publications
Last publications:
De Luca D, Foligno S, Autilio C, Vivanti A, Vanderkerckhove M, Martinovic J, Raschetti R, Guillot L, Touqui L. Secretory phospholipase A2 expression and activity in preterm clinical chorioamnionitis with fetal involvement. Am J Physiol Lung Cell Mol Physiol. 2022. Link.
Mercier J, Calmel C, Mésinèle J, Sutanto E, Merabtene F, Longchampt E, Sage E, Kicic A, Boëlle PY, Corvol H, Ruffin M and Guillot L. SLC6A14 impacts cystic fibrosis lung disease severity via mTOR and epithelial repair modulation. Front Mol Biosci. 2022. Link.
Mésinèle J, Ruffin M, Guillot L, Boëlle PY, Corvol H, On Behalf Of The French Cf Modifier Gene Study Investigators. Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis. J Pers Med. 2022. Link
Ruffin M, Bigot J, Calmel C, Mercier J, Givelet M, Oliva J, Pizzorno A, Manuel Rosa-Calatrava, Harriet Corvol, Viviane Balloy, Olivier Terrier and Loïc Guillot. Front Immunol. 2021. Link
Mercier J, Ruffin M, Corvol H, Guillot L. Gene Therapy: A Possible Alternative to CFTR Modulators? Front Pharmacol. 2021. Link
Sallenave JM, Guillot L. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? . Front Immunol. 2020 May 28;11:1229. Link
Paranjapye A, Ruffin M, Harris A, Corvol H. Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity. J Cyst Fibros. 2019 Nov 13. pii: S1569-1993(19)30963-4. Link
Bigot J, Guillot L, Guitard J, Ruffin M, Corvol H, Chignard M, Hennequin C, Balloy V. Respiratory Epithelial Cells Can Remember Infection: A Proof of Concept Study. J Infect Dis. 2019 Nov 3. pii: jiz569. Link
Aksit MA, Pace RG, Vecchio-Pagan B, Ling H, Rommens JM, Boelle PY, Guillot L, Raraigh KS, Pugh E, Zhang P, Strug LJ, Drumm ML, Knowles MR, Cutting GR, Corvol H, Blackman SM. Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits. J Clin Endocrinol Metab. 2019 Oct 19. pii: dgz102. Link
Boëlle PY, Debray D, Guillot L*, Corvol H*. SERPINA1 Z allele is associated with cystic fibrosis liver disease.; French CF Modifier Gene Study Investigators. Genet Med. 2019. *Co-last. Link
Perra L, Balloy V, Foussignière T, Moissenet D, Petat H, Mungrue IN, Touqui L, Corvol H, Chignard M, Guillot L. CHAC1 Is Differentially Expressed in Normal and Cystic Fibrosis Bronchial Epithelial Cells and Regulates the Inflammatory Response Induced by Pseudomonas aeruginosa. Front Immunol. 2018 Nov 29;9:2823. Link
Richard N, Marti L, Varrot A, Guillot L, Guitard J, Hennequin C, Imberty A, Corvol H, Chignard M, Balloy V. Human Bronchial Epithelial Cells Inhibit Aspergillus fumigatus Germination of Extracellular Conidia via FleA Recognition. Sci Rep. 2018 Oct 24;8(1):15699. Link
Corvol H, Mésinèle J, Douksieh IH, Strug LJ, Boëlle PY, Guillot L. SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis. Front Pharmacol. 2018Jul 26;9:828. Link
Boëlle PY, Debray D, Guillot L, Clement A, Corvol H Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.; French CF Modifier Gene Study Investigators. Hepatology. 2018Jul 30. doi: 10.1002/hep.30148. Link
All publications:
